Further research strategies for targeting MELK to treat glioblastoma should be focused on the following two aspects (1): development of MELK inhibitors with better permeability in the brain, and (2) using a nano-drug delivery system for direct transport of OTSSP167 into the brain to increase its concentration in the brain. The gene discussed is MELK; the disease is glioblastoma.